Wednesday, 30 December 2020

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment

Glenmark Pharmaceuticals Ltd has received final approval from the
United States Food and Drug Administration (USFDA) for Tadalafil
tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, the
company said in a regulatory filing.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-erectile-dysfunction-treatment/articleshow/80040795.cms

No comments:

Post a Comment